Latest News & Updates

Breaking News

  • 2 hours ago

  • Pharma Now Editorial Team

Cipla Launches Ciposcillo Oscillometer for Early Respiratory Diagnostics in COPD and Asthma
Breaking News
Medicus Pharma Achieves 55% Complete Response in Phase 2 BCC Trial, Advancing Toward FDA Registrational Discussions

Pharma Now Editorial Team

Other trending news you may like to read

Cipla Launches Ciposcillo Oscillometer for Early Respiratory Diagnostics in COPD and Asthma

Cipla launches Ciposcillo, a next-generation oscillometer targeting early diagnosis of COPD and asthma in the respiratory diagnostics segment.

Pharma Now Editorial Team

Pharma Now

Medicus Pharma Achieves 55% Complete Response in Phase 2 BCC Trial, Advancing Toward FDA Registrational Discussions

Medicus Pharma's 200µg D-MNA cohort hits 55% complete response at Day 57, advancing toward FDA End-of-Phase 2 discussions for nodular BCC.

Pharma Now Editorial Team

Pharma Now

Madrigal Pharmaceuticals Secures GalNAc-siRNA License with Arrowhead as Rezdiffra Hits Blockbuster Sales

Madrigal secures global rights to Arrowhead's GalNAc-siRNA ARO-PNPLA3 as Rezdiffra Q1 sales hit $311.3M, up 127% year-over-year.

Pharma Now Editorial Team

Pharma Now

Tonix Pharmaceuticals Secures GPO Coverage for TONMYA Reaching 35 Million Commercial Lives

Tonix secures GPO coverage for TONMYA sublingual tablets, reaching 35 million U.S. commercial lives as Medicare talks continue.

Pharma Now Editorial Team

Pharma Now